Beta-Blockers in Myocardial Infarction

Utilization of Beta blockers post-myocardial infarction.

Beta blockers provide both morbidity and mortality benefits for post-myocardial infarction (MI) patients. Despite this, beta blockers are still often underused or used at suboptimal dosages. This was a retrospective observational study with the objectives of estimating the proportion of post-MI patients who are receiving beta-blocker therapy in University Malaya Medical Centre (UMMC), assessing...

Beta-Blockers and Depression After Myocardial Infarction

OBJECTIVES The purpose of this research was to explore the prospective relationship between the use of beta-blockers and depression in myocardial infarction (MI) patients. BACKGROUND Beta-blocker use has been reported to be associated with the development of depression, but the methodological quality of studies in this field is weak. METHODS In a multicenter study, MI patients (n 127 non–beta-b...

Beta Blockers in Cardioprotection after Acute Myocardial Infarction

In post myocardial infarction patients beta blockers have shown a reduction of total mortality (23%), sudden cardiac death (25%) and non fatal reinfarction (30%). Beside beta blockers, only a few agents have shown reduction of mortality and sudden cardiac death in post myocardial infarction patients. Beta blockers have showed more favorable effects In patients with Q wave myocardial infarction ...

Why do beta-receptor blockers decrease mortality after myocardial infarction?

Beta blockers after myocardial infarction: have trials changed practice?

A survey of British consultant cardiologists was carried out to elicit their current practices when prescribing long term beta blockers after myocardial infarction. Sixty (72%) of the respondents reported that they used beta blockers prophylactically even in the absence of any other indications; the details of their stated policies, however, varied considerably. The favourable evidence of clini...